Senate Bill 17-192 Summary

• Allows state licensing authorities to suspend, fine, restrict, or revoke marijuana licenses for medical and retail operations whether the licenses are active, expired, or surrendered.

• Permits marijuana licensees a second test opportunity if initial test results show harmful substances; product may be used or sold if two additional tests show no contamination, or must be destroyed if remediation is impossible.

• Establishes different excise tax rates: 15% of average market rate for sales between affiliated marijuana businesses and 15% of contract price for sales between unaffiliated businesses, with quarterly market rate determination by the Department of Revenue.

• Defines "affiliated marijuana business licensees" as those owned or controlled by the same or related interests, and "contract price" as the actual invoice price charged for unprocessed retail marijuana excluding taxes and discounts.

• Appropriates $9,600 from the general fund and $59,458 from the marijuana cash fund to the Department of Revenue for tax administration and enforcement during fiscal year 2017-18, including 0.3 FTE for marijuana enforcement.